Strs Ohio Aerie Pharmaceuticals Inc Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 23, 2019	SELL	$33.0 - $60.04 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$56.15 - $73.9 $11,230 - $14,780	-200 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$47.85 - $70.45 $9,570 - $14,090	200 New	200 $13,000
Q4 2017 Jan 23, 2018	SELL	$50.85 - $65.1 $0 - $0	0 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$48.6 - $60.1 $0 - $0	0	0 $0

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.